[CAS NO. 34393-59-4] Cytidine 5'-diphosphate trisodium salt

Ships within

Stock

Price

Qty

Total

$0.00

Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis

request a quote

If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [34393-59-4]

Catalog

HY-W008915

Brand

MCE

CAS

34393-59-4

DESCRIPTION [34393-59-4]

Overview

MDL	MFCD00065201
Molecular Weight	469.12
Molecular Formula	C9H12N3Na3O11P2
SMILES	O[C@H]([C@H](O1)COP(OP(O[Na])(O[Na])=O)(O[Na])=O)[C@@H](O)[C@@H]1N2C=CC(N)=NC2=O

For research use only. We do not sell to patients.

Summary

Cytidine 5'-diphosphate trisodium salt (CDP) is produced by the transfer of phosphoryl group from ATP to cytidine monophosphate (CMP) catalyzed by uridine monophosphate kinase (UMPK). Cytidine 5′-diphosphate can be used to produce Cytidine triphosphate (CTP) for synthesis of DNA and RNA ^[1] ^[2] .

In Vivo

CDP-ribitol can be used for the Diagnostics and research of CDP-l-ribitol pyrophosphorylase A (CRPPA) muscular dystrophy ^[3] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Clinical Trial

NCT Number	Sponsor	Condition	Start Date	Phase
NCT03317353	Hospital Clinico Universitario de Santiago\|Instituto de Salud Carlos III\|European Regional Development Fund	Dizziness Chronic\|Fall\|Elderly	January 1, 2012	Not Applicable
NCT03034655	Hospital Clinico Universitario de Santiago\|Instituto de Salud Carlos III\|European Regional Development Fund	Dizziness Chronic\|Fall	January 1, 2016	Not Applicable
NCT02234674	Stendo	Primary Lower Limb Lymphedema\|Secondary Lower Limb Lymphedema	September 2014	Not Applicable
NCT01009242	UCB Pharma	Arthritis\|Rheumatoid Arthritis	October 2009	Phase 1\|Phase 2
NCT05262478	Ataturk University	Cervical Disc Disease	January 1, 2022

Appearance

Solid

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

-20°C, protect from light, stored under nitrogen

* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen)

Solvent & Solubility

In Vitro:

H ₂ O : 250 mg/mL ( 532.91 mM ; Need ultrasonic)

DMSO : < 1 mg/mL (ultrasonic;warming;heat to 80°C) (insoluble or slightly soluble)

Preparing
Stock Solutions

Concentration Solvent Mass	1 mg	5 mg	10 mg

1 mM	2.1317 mL	10.6583 mL	21.3165 mL
5 mM	0.4263 mL	2.1317 mL	4.2633 mL
10 mM	0.2132 mL	1.0658 mL	2.1317 mL

* Please refer to the solubility information to select the appropriate solvent.

In Vivo:

1.

Add each solvent one by one: PBS

Solubility: 100 mg/mL (213.17 mM); Clear solution; Need ultrasonic

* All of the co-solvents are available by MCE.

References

Synonyms

Cytidine 5′-(trihydrogen diphosphate), sodium salt (1:3)

Cytidine 5′-(trihydrogen diphosphate), trisodium salt

Cytidine 5′-(trihydrogen pyrophosphate), trisodium salt

Trisodium cytidine 5′-diphosphate

Cytidine diphosphate trisodium salt

Cytidine 5′-diphosphate trisodium salt